According to the Polaris Observatory, globally, the number of treated HCV patients increased 70% in 2016.

The total number of treated patients increased from approximately 1 million in 2015 to 1.7 million in 2016. The increase in treatment was most prominent in Egypt (577,000 patients treated in 2016 vs 200,000 in 2015), Pakistan (161,000 vs 65,000), India (115,000 vs 42,000), Brazil (45,000 vs 16,000), and Australia (32,000 vs 7,000). This increase was offset by a decrease in treatment in some high-income countries. The decline is presumably due to a shrinking pool of diagnosed/under-care population. Although the decline in treatment was not limited to high-income countries, the following countries accounted for approximately 75% of the total decline in 2016 – US (29,000 fewer patients treated in 2016 vs 2015), Spain (14,000 fewer), Japan (10,000 fewer), and Germany (15,000 fewer). For more details, see the Polaris Observatory.


Polaris Observatory was developed by:  
Made possible through funding from:
John Martin Foundation

Copyright © All rights reserved